CINECA IRIS Institutional Research Information System

VAISITTI, Tiziana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.617
AS - Asia 3.173
EU - Europa 3.101
SA - Sud America 414
AF - Africa 130
OC - Oceania 17
Totale 11.452
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.506
SG - Singapore 1.195
CN - Cina 1.164
IT - Italia 1.164
BR - Brasile 329
DE - Germania 305
IE - Irlanda 270
SE - Svezia 261
UA - Ucraina 189
VN - Vietnam 188
AT - Austria 168
FR - Francia 151
KR - Corea 150
FI - Finlandia 142
GB - Regno Unito 134
HK - Hong Kong 103
IN - India 77
JP - Giappone 74
CA - Canada 68
SN - Senegal 68
PL - Polonia 67
ES - Italia 52
ID - Indonesia 36
NL - Olanda 34
MX - Messico 31
AR - Argentina 29
BE - Belgio 27
CZ - Repubblica Ceca 23
TR - Turchia 23
ZA - Sudafrica 20
CH - Svizzera 16
IQ - Iraq 16
IR - Iran 16
RU - Federazione Russa 16
EG - Egitto 15
TW - Taiwan 15
UZ - Uzbekistan 15
AU - Australia 14
BD - Bangladesh 13
BY - Bielorussia 13
CL - Cile 13
DK - Danimarca 12
EC - Ecuador 11
SA - Arabia Saudita 11
AE - Emirati Arabi Uniti 9
CO - Colombia 9
RO - Romania 9
GR - Grecia 8
LB - Libano 8
MO - Macao, regione amministrativa speciale della Cina 8
PH - Filippine 8
PK - Pakistan 8
VE - Venezuela 8
LT - Lituania 7
MA - Marocco 7
NG - Nigeria 6
IL - Israele 5
PY - Paraguay 5
UY - Uruguay 5
KZ - Kazakistan 4
LU - Lussemburgo 4
NO - Norvegia 4
NP - Nepal 4
PE - Perù 4
PT - Portogallo 4
TH - Thailandia 4
CR - Costa Rica 3
DZ - Algeria 3
EE - Estonia 3
HR - Croazia 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
BG - Bulgaria 2
BH - Bahrain 2
HU - Ungheria 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LV - Lettonia 2
MD - Moldavia 2
ML - Mali 2
NI - Nicaragua 2
PA - Panama 2
PS - Palestinian Territory 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BO - Bolivia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GH - Ghana 1
GM - Gambi 1
GT - Guatemala 1
JM - Giamaica 1
JO - Giordania 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
MM - Myanmar 1
Totale 11.439
Salva come PNG Salva come JPEG
Città #
Singapore 654
Chandler 585
Ashburn 459
Beijing 446
Santa Clara 309
Dublin 269
Torino 263
Turin 216
Houston 164
Ann Arbor 156
Vienna 147
Nyköping 136
Fairfield 132
Columbus 95
Milan 94
Jacksonville 90
Wilmington 89
Seoul 87
Los Angeles 86
Medford 81
Princeton 81
Hong Kong 79
Hefei 74
Redwood City 67
Villeurbanne 65
Dearborn 63
Guangzhou 62
Dallas 60
Munich 59
Woodbridge 59
New York 58
Dong Ket 55
Nuremberg 55
Shanghai 55
Warsaw 51
Boston 50
Buffalo 50
Centro 50
The Dalles 50
Cambridge 48
Fremont 48
Seattle 47
Hangzhou 42
Ho Chi Minh City 39
San Mateo 30
Boardman 29
Jakarta 29
Nanjing 29
Tokyo 29
Düsseldorf 28
Helsinki 28
Hanoi 27
São Paulo 26
Pisa 25
San Diego 25
Rome 24
Turku 24
Rio de Janeiro 20
London 19
Toronto 19
Brussels 18
Bengaluru 16
Frankfurt am Main 16
Redondo Beach 16
Chengdu 15
Garessio 15
Xian 15
Mexico City 13
San Francisco 13
Shenyang 13
Silver Spring 13
Wuhan 13
Barcelona 12
Genoa 12
Novara 12
Phoenix 12
Stockholm 12
Brooklyn 11
Chicago 11
Madrid 11
Perugia 11
Falls Church 10
Lappeenranta 10
Tianjin 10
Brasília 9
Brookline 9
Chennai 9
Kunming 9
Vestignè 9
Wroclaw 9
Amsterdam 8
Bologna 8
Denver 8
Detroit 8
Hebei 8
Naples 8
Norwalk 8
Taipei 8
Austin 7
Brisbane 7
Totale 6.778
Salva come PNG Salva come JPEG
Nome #
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. 868
Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications. 604
Mutations in NOTCH1 PEST-domain orchestrate CCL19-driven homing of Chronic Lymphocytic Leukemia cells by modulating the tumor suppressor gene DUSP22 445
Subcellular characterization of NAD+ biosynthesis in metastatic melanoma by using organelle-specific biosensors 387
Clinical exome sequencing is a powerful tool in the diagnostic flow of monogenic kidney diseases: an Italian experience 219
SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response 199
Targeting metabolism and survival in chronic lymphocytic leukemia and richter syndrome cells by a novel NF-κB inhibitor 188
Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma 174
SLAMF1/CD150 IS A SIGNALING RECEPTOR EXPRESSED BY A SUBSET OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS CHARACTERIZED BY A FAVORABLE PROGNOSIS 168
Immune response dysfunction in chronic lymphocytic leukemia: Dissecting molecular mechanisms and microenvironmental conditions 165
NAD+-metabolizing ecto-enzymes shape tumor-host interactions: the chronic lymphocytic leukemia model. 155
Adult-onset CblC deficiency: a challenging diagnosis involving different adult clinical specialists 154
Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment 153
USE OF CLINICAL EXOME SEQUENCING IN THE DIAGNOSTIC FLOW OF MONOGENIC KIDNEY DISEASES: THE PIEDMONT EXPERIENCE 153
Nampt over-expression recapitulates the braf inhibitor resistant phenotype plasticity in melanoma 153
The NOTCH Pathway and Its Mutations in Mature B Cell Malignancies 152
ROR1 targeting with the antibody-drug conjugate VLS-101 is effective in Richter syndrome patient–derived xenograft mouse models 148
CD73-Generated Extracellular Adenosine Creates Microenvironmental Conditions Favoring Growth and Survival of Chronic Lymphocytic Leukemia Cells 146
NOVEL AND KNOWN MUTATIONS IDENTIFIED BY CLINICAL EXOME SEQUENCING FOR THE DIAGNOSIS OF POLYCYSTIC KIDNEY DISEASE 146
B Cell Receptor signaling and genetic lesions in TP53 and CDKN2A/CDKN2B cooperate in Richter Transformation 142
Slamf-1/CD150 Is a Signaling Receptor Expressed by a Subset of Chronic Lymphocytic Leukemia Patients Characterized by a Favorable Prognosis 138
CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death 138
Abstract 5170: Metabolism and cancer: The CD38-NAMPT connection in chronic lymphocytic leukemia 138
Abstract 2630: Nicotinamide activates the p53/miR-34a/SIRT1 tumor suppressor network leading to apoptosis of chronic lymphocytic leukemia cells 138
Adenosine Signaling Mediates Hypoxic Responses in the Chronic Lymphocytic Leukemia Microenvironment 137
CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential 134
CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells 133
Mutations in NOTCH1 PEST Domain Orchestrate CCL19-Driven Homing of Chronic Lymphocytic Leukemia (CLL) Cells By Modulating the Gene DUSP22 133
CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunity 132
A novel COLEC10 mutation in a child with 3MC syndrome 129
Abstract 2302: The extracellular form of NAMPT contributes to creating a proinflammatory environment in chronic lymphocytic leukemia 128
HLA and AB0 Polymorphisms May Influence SARS-CoV-2 Infection and COVID-19 Severity 127
Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology 125
Chronic lymphocytic leukemia 124
CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival 123
The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy 120
Extracellular Nicotinamide Phosphoribosyltransferase (NAMPT) Shapes the CLL Microenvironment Promoting Macrophage M2 Polarization Via a Non-Enzymatic Mechanism 120
Multiple metamorphoses of CD38 from prognostic marker to disease modifier to therapeutic target in chronic lymphocytic leukemia. 120
Cationization of monoclonal antibodies: another step towards the 'magic bullet'? 118
HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study. 117
The PD-1/PD-L1 Axis Contributes to T Cell Dysfunction in Chronic Lymphocytic Leukemia 112
Targeting the Adenosinergic Axis in the Eμ-TCL1 Chronic Lymphocytic Leukemia Mouse Model Offers Novel Therapeutic Opportunities 112
CD38 at the junction between prognostic marker and therapeutic target 109
SLAMF1/CD150 Activates Autophagy in Chronic Lymphocytic Leukemia Cells, Modulating Chemotaxis and Responses to Therapy 109
The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting. 106
Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia 105
Validation of a Simple, Rapid, and Cost-Effective Method for Acute Rejection Monitoring in Lung Transplant Recipients 103
In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia 103
The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells. 103
CD38 in chronic lymphocytic leukemia: from bench to bedside? 102
Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia. 101
Alteration of BIRC3 and multiple other NF-kappaB pathway genes in splenic marginal zone lymphoma. 98
Ectonucleotidases in Blood Malignancies: A Tale of Surface Markers and Therapeutic Targets 98
CD38 signals up-regulate expression and functions of matrix metalloproteinase-9 in chronic lymphocytic leukemia cells. 96
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome 96
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 95
CD38 as a molecular compass guiding topographical decisions of chronic lymphocytic leukemia cells 94
CD38/CD19: a lipid raft dependent signaling complex in human B cells 93
The frequency of rare and monogenic diseases in pediatric organ transplant recipients in Italy 91
E2A is a transcriptional regulator of CD38 expression in chroniclymphocytic leukemia 89
Novel Approaches for the Treatment of Patients with Richter’s Syndrome 89
Anti-CD37 α-amanitin–conjugated antibodies as potential therapeutic weapons for Richter syndrome 87
Targeting of the A2A adenosine receptor counteracts immunosuppression in vivo in a mouse model of chronic lymphocytic leukemia 87
Complementary approaches define the metabolic features that accompany Richter syndrome transformation 86
CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells 86
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development. 85
Synergistic efficacy of the dual PI3K-δ/γ inhibitor duvelisib with the Bcl-2 inhibitor venetoclax in Richter syndrome PDX models 85
Targeting the microenvironment in chronic lymphocytic leukemia offers novel therapeutic options. 84
CD38/CD31 interactions activate genetic pathways leading toproliferation and migration in chronic lymphocytic leukemia cells 83
Targeting the adenosinergic axis in chronic lymphocytic leukemia: A way to disrupt the tumor niche? 82
Relevance of next generation sequencing (NGS) data re-analysis in the diagnosis of monogenic diseases leading to organ failure 80
Novel richter syndrome xenograft models to study genetic architecture, biology, and therapy responses 76
Lift the curtain on long non-coding RNAs in hematological malignancies: Pathogenic elements and potential targets 76
Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia 75
The humoral and cellular response to mRNA SARS-CoV-2 vaccine is influenced by HLA polymorphisms 75
The role of genetic testing in the diagnostic workflow of pediatric patients with kidney diseases: the experience of a single institution 73
Nicotinamide Blocks Proliferation and Induces Apoptosis of Chronic Lymphocytic Leukemia Cells through Activation of the p53/miR-34a/SIRT1 Tumor Suppressor Network. 70
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild type chronic lymphocytic leukemia. 66
Functional evaluation of a novel nonsense variant of the calcium-sensing receptor gene leading to hypocalcemia 62
Matching clinical and genetic data in pediatric patients at risk of developing cystic kidney disease 59
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness. 59
A new taxonomy for splenic marginal zone lymphoma 57
A molecular circuit linking the BCR to the NAD biosynthetic enzyme NAMPT is an actionable target in Richter syndrome 56
Regulation Of CLL Growth and Trafficking By The Enzymatic Functions Of CD38: Implications For Therapeutic Targeting 55
Donor-derived Cell-free DNA Evaluation in Pediatric Heart Transplant Recipients: A Single-center 12-mo Experience 54
Circulating cell-free DNA in liver transplantation: A pre- and post-transplant biomarker of graft dysfunction 49
Apoliprotein E-mediated ferroptosis controls cellular proliferation in chronic lymphocytic leukemia 47
LINC00152 expression in normal and Chronic Lymphocytic Leukemia B cells 46
Genomic and Transcriptomic Profile of HNF1A-Mutated Liver Adenomas Highlights Molecular Signature and Potential Therapeutic Implications 45
In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities 44
Technical Advances in Circulating Cell-Free DNA Detection and Analysis for Personalized Medicine in Patients’ Care 44
Macrophage- and BCR-derived but not TLR-derived signals support the growth of CLL and Richter syndrome murine models in vivo 43
Decreased apoptotic priming and loss of BCL-2 dependence are functional hallmarks of Richter’s syndrome 40
Totale 11.711
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.968
article - articoli 0
book - libri 0
conference - conferenze 6.586
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.554
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021780 0 0 0 0 0 75 145 93 176 94 62 135
2021/20221.290 77 59 63 86 73 131 87 65 55 131 288 175
2022/20231.672 174 182 38 172 119 368 104 113 196 67 78 61
2023/2024980 109 154 57 37 92 114 41 100 21 60 87 108
2024/20252.556 46 146 84 238 510 215 88 125 379 177 221 327
2025/20262.191 571 266 291 498 436 129 0 0 0 0 0 0
Totale 11.711